✦ LIBER ✦

Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation

✍ Scribed by Josep-María Ribera; Olga García; Pau Montesinos; Salut Brunet; Eugenia Abella; Manuel Barrios; José González-Campos; Pilar Bravo; Maria-Luz Amigo; Jesús-María Hernández-Rivas

Book ID: 117946821
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 151 KB
Volume: 159
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09240.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Philadelphia chromosome-positive acute l

Philadelphia chromosome-positive acute lymphoblastic leukemia: Impact of imatinib treatment on remission induction and allogeneic stem cell transplantation

✍ Tibor Kovacsovics; Richard T. Maziarz 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 325 KB

Successful Treatment of Minimal Residual

Successful Treatment of Minimal Residual Disease—Positive Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia with Imatinib Followed by Reduced-Intensity Unrelated Cord Blood Transplantation after Allogeneic Peripheral Blood Stem Cell Transplantation

✍ Akiyoshi Takami; Shigeru Shimadoi; Chiharu Sugimori; Kenichi Takemoto; Masami Sh 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 92 KB

Case of a patient with Philadelphia-chro

Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions

✍ Makoto Yoshimitsu; Hiroshi Fujiwara; Atsuo Ozaki; Heiichiro Hamada; Kakushi Mats 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 163 KB

Intermediate dose of imatinib in combina

Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005

✍ Susana Rives; Jesús Estella; Pedro Gómez; Mónica López-Duarte; Purificación Garc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Long-Term Follow-up of Allogeneic Hemato

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes

✍ Partow Kebriaei; Rima Saliba; Gabriela Rondon; Alexandre Chiattone; Rajyalakshmi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 237 KB

The extent of minimal residual disease r

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af